Amgen Submits Supplemental Biologics License Application For Nplate® (romiplostim)

Author's Avatar
Dec 19, 2018
Article's Main Image

Application Seeks to Include Adult Patients who Have had Immune Thrombocytopenia for 12 Months or Less

PR Newswire